IMRIS Inc. and Siemens Healthcare announced that the companies have strengthened their sales collaboration through a new agreement that positions one of Siemens' most innovative computed tomography (CT) products as the core of the IMRIS VISIUS iCT solution. Developed for the neurosurgery and spine surgery markets, the VISIUS iCT has at its core the 64- slice Siemens SOMATOM(R) Definition AS scanner. IMRIS received U.S. Food and Drug Administration (FDA) 510(k) clearance for VISIUS iCT in July.

The company currently has systems sold to three major eastern US neurosciences centers.